Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Asarfi Hospital Ltd

BSE: 543943 · Diversified Consumer Services · 16 announcements

Share price
₹187.60
Market cap
₹369.1 Cr
Revenue (annual)
₹173.5 Cr
Net profit (annual)
₹16.66 Cr
P/E (TTM)
22.2×Sector 34.2×
Promoter holding
61.17%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

19:27 IST BSE
Annual General Meeting

Asarfi Hospital Annual General Meeting

Asarfi Hospital Ltd's 21st Annual General Meeting held on September 18, 2026, saw shareholder approval for financial statements, director reappointment, and migration to the BSE Main Board.

18:20 IST BSE
Annual Report

Asarfi Hospital Annual Report

Asarfi Hospital Limited has submitted its Annual Report for the Financial Year 2025-26 in compliance with SEBI Listing Regulations.

16:29 IST BSE
Other Announcement

Asarfi Hospital Other Announcement

Asarfi Hospital Limited has appointed M/s Ashutosh Kumar Sinha & Co as the Cost Auditor for the financial year 2026-27, as approved by the Board.

19:23 IST BSE
Board Meeting Outcome

Asarfi Hospital Board Meeting Outcome

Asarfi Hospital approved its 21st AGM, appointment of auditors, and migration from BSE SME to the BSE Main Board and NSE.

23:04 IST BSE
Board Meeting Date

Asarfi Hospital Board Meeting Date

Asarfi Hospital Ltd has scheduled a board meeting for August 25, 2026, to discuss the AGM and proposed migration to the BSE Main Board.

19:06 IST BSE
Financial Results

Asarfi Hospital Q1 FY27 Results: Net Profit ₹4.3 Cr, Up 38.7% YoY

Asarfi Hospital Ltd reported revenue from operations of ₹47.5 Cr (+33.1% YoY) and net profit of ₹4.3 Cr (+38.7% YoY) for Q1 FY27.

Key figure
Net profit ₹4.3 Cr · +38.7% YoY
18:32 IST BSE
Financial Results

Asarfi Hospital Q1 FY27 Results: Net Profit ₹4.3 Cr, Up 38.7% YoY

Asarfi Hospital Ltd reported revenue from operations of ₹47.5 Cr (+33.1% YoY) and net profit of ₹4.3 Cr (+38.7% YoY) for Q1 FY27.

Key figure
Net profit ₹4.3 Cr · +38.7% YoY
19:30 IST BSE
Board Meeting Date

Asarfi Hospital Board Meeting Date

Asarfi Hospital Ltd has scheduled a board meeting on August 7, 2026, to consider and approve the unaudited financial results for the quarter ending June 30, 2026.

19:48 IST BSE
Board Meeting Outcome

Asarfi Hospital Board Meeting Outcome

Asarfi Hospital's board approved participating in a PPP Medical College project. This includes a refundable bid security of ₹3.52 Crore.

Value
₹3.52 Cr
12:35 IST BSE
Fund Raise

Asarfi Hospital Fund Raise of ₹26.94 Cr

Asarfi Hospital Limited reported zero deviation in the utilization of ₹26.94 Crore raised via its IPO. Funds were deployed for hospital capital expenditure and land acquisition.

Value
₹26.94 Cr
11:21 IST BSE
Earnings Call

Asarfi Hospital Earnings Call: Key Takeaways

Asarfi Hospital Limited reported strong FY26 performance with 42% revenue growth and 58% PAT growth. Management targets scaling to 500+ beds and INR 400cr revenue by FY28.

18:39 IST BSE
Results Update

Asarfi Hospital Results Update

Asarfi Hospital Ltd reported ₹173.5 Crore revenue for FY26, a 42% YoY increase. EBITDA margins reached 20%, driven by improved realizations and specialty-led growth.

Value
₹173.5 Cr
18:50 IST BSE
Financial Results

Asarfi Hospital H2 FY26 Results: Net Profit ₹9.3 Cr, Up 47.6% YoY

Asarfi Hospital Ltd reported revenue from operations of ₹92.1 Cr (+36.2% YoY) and net profit of ₹9.3 Cr (+47.6% YoY) for H2 FY26.

Key figure
Net profit ₹9.3 Cr · +47.6% YoY
17:59 IST BSE
Financial Results

Asarfi Hospital Financial Results

Asarfi Hospital Limited approved audited standalone and consolidated financial results for the fiscal year ended March 2026. The results received an unmodified opinion from auditors.

23:57 IST BSE
Board Meeting Date

Asarfi Hospital Board Meeting Date

Asarfi Hospital Limited has scheduled a Board Meeting for May 11, 2026, to approve audited financial results for the year ended March 31, 2026. The company also announced a trading window closure from April 1 to May 31, 2026, for designated persons.